Author:
Yadav Babita,Talekar Manisha,Ahmad Azeem,Jameela Sophia,Khanduri Shruti
Reference34 articles.
1. Younossi ZM, Koenig AB, Abdelatif D, Fazel Y, Henry L, Wymer M Global epidemiology of non-alcoholic fatty liver disease-meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology 2016;64:73-84.
2. Diehl AM, Day C Cause, pathogenesis, and treatment of non-alcoholic steatohepatitis. N Engl J Med 2017;377:2063-72.
3. Ascha MS, Hanouneh IA, Lopez R, Tamimi TA, Feldstein AF, Zein NN The incidence and risk factors of hepatocellular carcinoma in patients with non-alcoholic steatohepatitis. Hepatology 2010;51:1972-8.
4. NAFLD and liver transplantation: Current burden and expected challenges;Pais;J Hepatol,2016
5. Association between fibrosis stage and outcomes of patients with non-alcoholic fatty liver disease: A systematic review and meta-analysis;Taylor;Gastroenterology,2020